Bio Fire Diagnostics
BioFire Diagnostics sets the standard for molecular diagnostics through its pioneering advances in syndromic infectious disease testing. As BioMérieux’s Global Center of Excellence for Molecular Diagnostics, no other company has FDA-cleared and CE-IVD marked assays for more pathogens. BioFire Diagnostics has produced the easiest, fastest, and most comprehensive multiplex PCR testing available: the BioFire FilmArray System. The BioFire System helps healthcare providers improve patient care and satisfaction by providing faster and better results. BioFire Syndromic Trends is a cloud-based network that compiles real-time pathogen data from labs all over the world.
With more than 25 years of molecular experience and as bioMérieux’s Global Center of Excellence for Molecular Diagnostics, BioFire sets the standard for molecular diagnostics through its pioneering advances in syndromic infectious disease testing.
The FDA-cleared BioFire System panels test for viruses, bacteria, parasites, yeast, and antimicrobial resistance genes. Whether you’re trying to determine optimal therapy for a septic patient or pinpoint which respiratory pathogen is making a young child sick, the BioFire System can provide definitive answers—fast.
BioFire simplifies our customers’ lives by innovating easy-to-use clinical molecular diagnostic solutions that provide fast and accurate results. Our mission is simple and important: to help make the world a healthier place.
Many infections present with similar signs and symptoms. But today’s targeted infectious disease diagnostics limit testing to only the most common pathogens associated with a clinical syndrome. This leaves most infections undiagnosed and leads to additional downstream testing, patient dissatisfaction, and compromised patient care.
BioFire’s syndromic approach to infectious disease diagnostics is changing all of that.
The syndromic approach is a symptom-driven diagnostic method that combines a broad grouping of probable pathogenic causes into a single, rapid test. This allows physicians to easily choose the right test, the first time.
Our innovative team leads the industry in infectious disease diagnostics and provides molecular solutions that lessen the time to medical results, empower healthcare professionals to make better diagnostic decisions, and lower healthcare costs. We are committed to improving the quality of life for everyone, everywhere, every day.